https://www.taxtmi.com/highlights?id=66526 Revision u/s 263 - deduction claimed towards R&D expenditure incurred for Bio-pharma division - AO without considering relevant facts simply allowed the claim of the assessee. Therefore, in our considered view, the assessment order passed by the AO is erroneous and also prejudicial to the interest of the revenue, because the AO failed to carry out required inquires or verifications which should have been made in the given facts and circumstances of the case. - AT en-us Mon, 14 Nov 2022 12:52:28 +0530 Mon, 14 Nov 2022 12:52:28 +0530 TaxTMI RSS Generator https://www.taxtmi.com/highlights?id=66526 Revision u/s 263 - deduction claimed towards R&D expenditure incurred for Bio-pharma division - AO without considering relevant facts simply allowed the claim of the assessee. Therefore, in our considered view, the assessment order passed by the AO is erroneous and also prejudicial to the interest of the revenue, because the AO failed to carry out required inquires or verifications which should have been made in the given facts and circumstances of the case. - AT Highlights Income Tax Mon, 14 Nov 2022 12:52:28 +0530 https://www.taxtmi.com/highlights?id=66526